Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF copper in schizophrenia.

S P Tyrer, H T Delves, M P Weller

    The American Journal of Psychiatry
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Schizophrenia patients show lower copper levels in cerebrospinal fluid compared to controls. This finding supports the theory of reduced activity of copper-dependent enzymes crucial for dopamine regulation in schizophrenia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification and apportionment of sources of lead in human tissue.

    Environmental geochemistry and health·2013
    Same author

    Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.

    Journal of intellectual disability research : JIDR·2007
    Same author

    Blood indices of selenium and mercury, and their correlations with fish intake, in young people living in Britain.

    The British journal of nutrition·2006
    Same author

    A problem with her lead weight.

    Annals of clinical biochemistry·2005
    Same author

    Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus.

    Archives of disease in childhood. Fetal and neonatal edition·2004
    Same author

    Influence of the amyloid precursor protein locus on dementia in Down syndrome.

    Neurology·2004
    Same journal

    2026 Annual Meeting: President-Elect Address.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: CEO and Medical Director's Address.

    The American journal of psychiatry·2026
    Same journal

    Reports to the Membership.

    The American journal of psychiatry·2026
    Same journal

    Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: Presidential Address.

    The American journal of psychiatry·2026
    Same journal

    Represcribing Previously Used Antipsychotics: Response to So.

    The American journal of psychiatry·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Psychiatry

    Background:

    • Schizophrenia is a complex psychiatric disorder with multifactorial etiology.
    • Dopamine pathways are implicated in the pathophysiology of schizophrenia.
    • Copper is an essential cofactor for several enzymes involved in neurotransmitter synthesis.

    Purpose of the Study:

    • To investigate copper levels in the cerebrospinal fluid (CSF) of individuals with schizophrenia.
    • To explore the relationship between CSF copper and the activity of copper-dependent enzymes in schizophrenia.

    Main Methods:

    • Cerebrospinal fluid (CSF) samples were collected from 8 individuals diagnosed with schizophrenia.
    • CSF samples were also collected from 6 healthy control subjects.
    • Copper concentrations in CSF were measured using a validated analytical method.

    Related Experiment Videos

    Main Results:

    • Significantly lower copper levels were observed in the CSF of schizophrenic subjects compared to the control group.
    • This reduction in CSF copper suggests potentially decreased activity of copper-dependent enzymes.

    Conclusions:

    • Reduced central copper levels may contribute to the neurochemical alterations observed in schizophrenia.
    • The findings support the hypothesis of impaired function of copper-dependent enzymes, such as tyrosine hydroxylase and dopamine-beta-hydroxylase, in schizophrenia.